Local drug manufacturing in Nigeria: where API intermediates from India fit
Local drug manufacturing in Nigeria has grown considerably but the vast majority of the factories are still reliant on imported inputs. The APIs and the intermediates which go into the APIs are predominantly sourced from India and China. For a company that is looking to manufacture more drugs in-house the supply of those inputs is as important as the plant itself.
For the Nigerian buyer the real issue is where the API intermediates fit in and how to source them from India without any delays at the port.
The pharmaceutical industry in Nigeria today (as of 2026)
Nigeria has over 100 registered drug manufacturers and government policy is very much in favour of local output. There was an executive order which removed import duty and taxes on raw materials and equipment for local pharma production. The national target is 70% local production by 2030. Recent reports suggest the current level is around 38%.
NAFDAC’s 5+5 policy pushes in the same direction. It asks companies that import finished medicines to start local production, or partner with a local manufacturer, after their registration renewals. Recent figures show 66 products have already moved from import to local manufacture under the policy. Each of these shifts adds demand for local drug manufacturing in Nigeria and for the inputs that feed it.
What API intermediates are, in plain terms
Every medicine starts as chemistry and ends as a tablet. A key starting material becomes an intermediate. The intermediate becomes the API, and a factory then turns the API into tablets or capsules. Intermediates are the step just before the API.
Today, most local drug manufacturing in Nigeria happens at that last stage, where factories turn imported APIs into finished products. That will change as the first local API projects come online. An API plant needs intermediates as its main raw material.
How pharmaceutical raw materials suppliers in Nigeria fit in
Intermediates usually reach Nigerian plants via one of two routes. Some of the API projects and the contract manufacturers themselves will buy directly from the producer in India. Others work through pharmaceutical raw materials suppliers in Nigeria who import the material and then have it in stock for the smaller customers.
Both routes work. Buying direct generally gives you better technical support and traceability. A local supplier is obviously better for smaller volumes and for getting items off the shelf quickly.
Indian pharmaceutical companies in Nigeria are already a familiar presence. According to UN trade data, India exported pharmaceutical products worth US$636.63 million to Nigeria in 2025. Most Nigerian buyers already know how Indian paperwork and shipments work.
Therapy areas for pharmaceutical manufacturing companies in Nigeria
Blood pressure and diabetes are the two that stand out. The State of Health of the Nation Report 2025 estimated that 35-40% of Nigerian adults had high blood pressure. National surveys have put the figure for diabetes at between 4.7% and 8% depending on the study.
These figures matter for pharmaceutical manufacturing companies in Nigeria when they plan their product range. Blood pressure medicines such as losartan rely on sartan intermediates. Glibenclamide, a widely used diabetes medicine, starts from Glibenclamide Sulfonamide. Both conditions need lifelong treatment, so these two areas will keep local drug manufacturing in Nigeria busy for years.
5 steps to source intermediates for local drug manufacturing in Nigeria
- Share your specification and volumes. Send the purity and impurity limits you need, plus your expected monthly or yearly volumes. A clear brief saves weeks of back-and-forth.
- Ask for a certificate of analysis and a sample. Then test the sample against your specification, in your own lab or a qualified third-party lab.
- Check the supplier’s quality systems. Ask about GMP compliance and how the team handles deviations. If possible, arrange a site visit or a remote audit.
- Agree on import documents early. Your bank must open a Form M before shipment. Pharmaceutical inputs also fall under the National Agency for Food and Drug Administration and Control (NAFDAC). Confirm current requirements with NAFDAC, and agree which documents your supplier will provide.
- Plan lead times and packaging. Sea freight from western India to Lagos takes several weeks, so build that into your production plan. Agree on packaging that protects the material in transit and storage.
How we support buyers in Nigeria
PYG Lifesciences is an API intermediates manufacturer in India, based in Gujarat. We make sartan intermediates and Glibenclamide Sulfonamide in a GMP-compliant plant, and our lab tests every batch by HPLC and GC. You can see the full range on our products page.
In our experience, buyers who sort out documents and lead times before the first order face far fewer delays at the port. That planning will matter more as local drug manufacturing in Nigeria moves from finished products towards APIs.
Planning a local manufacturing project?
Are you sourcing intermediates for local drug manufacturing in Nigeria, such as blood pressure or diabetes medicines? Send your specification and expected volumes to info@pyglifesciences.com. Our team will reply with technical details and an indicative lead time.
Frequently Asked Questions (FAQs)